ANUH PHARMA LTD. has reported Standalone financial results for the period ended June 30, 2022.
Financial Results (Q1 FY2023) - QoQ Comparison
The company has reported total income of Rs. 117.3315 crores during the period ended June 30, 2022 as compared to Rs. 129.9987 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs. 7.3353 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 8.9255 crores for the period ended March 31, 2022.
The company has reported EPS of Rs. 1.46 for the period ended June 30, 2022 as compared to Rs. 1.78 for the period ended March 31, 2022.
Total Income | ₹ 117.3315 crs | ₹129.9987 crs | -9.74% |
Net Profit | ₹7.3353 crs | ₹8.9255 crs | -17.82% |
EPS | ₹1.46 | ₹1.78 | -17.98% |
Financial Results (Q1 FY2023) - YoY Comparison The company has reported total income of Rs. 117.3315 crores during the period ended June 30, 2022 as compared to Rs.119.1962 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs.7.3353 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.5.5903 crores for the period ended June 30, 2021.
The company has reported EPS of Rs.1.46 for the period ended June 30, 2022 as compared to Rs.1.12 for the period ended June 30, 2021.
Total Income | ₹ 117.3315 crs | ₹119.1962 crs | -1.56% |
Net Profit | ₹7.3353 crs | ₹5.5903 crs | 31.21% |
EPS | ₹1.46 | ₹1.12 | 30.36% |
Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 101.00 as compared to the previous close of Rs. 105.60. The total number of shares traded during the day was 23648 in over 237 trades.
The stock hit an intraday high of Rs. 105.65 and intraday low of 100.00. The net turnover during the day was Rs. 2427681.00.
Source : Equity Bulls
Keywords
AnuhPharma
Q1FY23
ResultUpdate